Venom Allergy Guidelines
JTF Practice Parameters and Guidelines The Joint Task Force (JTF) on Practice Parameters was formed in 1989 and is comprised of members from the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology. This Guideline published by the European Academy of Allergy and Clinical Immunology (EAACI) has drawn on data from a systematic review of the literature, more recent published studies and multi. The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Insect Venom Allergy.
We seek to critically assess the effectiveness. Included in this guideline are epidemiology, risk factors, clinical features, diagnostic tests, the natural history of Hymenoptera venom allergy and guidance on undertaking venom immunotherapy (VIT). There are also separate sections on children, elevated baseline tryptase and mastocytosis and mechanisms underlying VIT.
This was a retrospective chart review of patients with suspected venom allergy who underwent skin testing at 4 allergy clinics within a single health care system from 2012 to 2022. Demographic data, test protocol (standard vs accelerated), test results, and adverse reactions were reviewed. In individuals for whom venom immunotherapy (VIT) is recommended, the treatment section outlines the nuts and bolts of VIT including instructions on venom dilution and examples of various build-up protocols.
This chapter closes with information on the prevention of stings, risk factors for severe reactions, and a section on biting insect allergy. Allergy Clin Immunol. 2004;114:869e886), and there was an update in 2011 highlighting advances in diagnosis and manage-ment of insect sting allergy (Golden DBK, Mof tt J, Nicklas RA, fi AAAAI.
Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127:852e854).
Diagnostic testing of patients who present for evaluation of insect venom allergy can involve many levels of investigation. A detailed initial history is critical for diagnosis and prognosis. The severity of previous sting reactions and the presence or absence of urticaria or hypotension predict severe future sting reactions and underlying mast cell disorders.
Venom skin tests and specific IgE. This guideline aims to give practical advice on performing venom immunotherapy. Key sections cover general considerations before initiating venom immunotherapy, evidence-based clinical recommendations, risk factors for adverse events and for relapse of systemic sting reaction, and a summary of gaps in the evidence.
This guideline aims to give practical advice on performing venom immunotherapy. Key sections cover general considerations before initiating venom immunotherapy, evidence-based clinical recommendations, risk factors for adverse events and for relapse of systemic sting reaction, and a summary of gaps in the evidence. (Allergy.
2018 Apr;73 (4):744.